Communiqués HLS Therapeutics Inc.

Actions

HLS

CA40390B1094

Produits pharmaceutiques

Marché Fermé - Toronto S.E. Autres places de cotation 22:00:00 10/08/2026			Varia. 5j.	Varia. 1 janv.
3,920 ^CAD	-2,73 %		-6,67 %	-18,67 %

26/06	Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call
23/06	HLS Therapeutics lance son offre de rachat d'actions dans le cours normal des activités	MT

Communiqués

05/08	HLS Therapeutics Provides Update on NILEMDO™ Market Access	AQ
29/07	HLS Therapeutics to Host Q2 2026 Financial Results Conference Call	AQ
26/06	HLS Therapeutics Reports Annual Meeting Results	AQ
23/06	HLS Therapeutics Announces Normal Course Issuer Bid	AQ
15/05	HLS Therapeutics : First Quarter 2026 Presentation	PU
15/05	HLS Therapeutics Announces Q1 2026 Financial Results	AQ
01/05	HLS Therapeutics to Host Q1 2026 Financial Results Conference Call	AQ
23/04	HLS Therapeutics : Investor Presentation	PU
14/04	HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference	AQ
12/03	HLS Therapeutics : 2026 Annual Report 2026 Annual Information Form	PU
12/03	HLS Therapeutics Announces Fiscal 2025 Financial Results	AQ
26/02	HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call	AQ
13/11	HLS Therapeutics : Q3 2025 Conference Call Presentation	PU
13/11	HLS Therapeutics : Third Quarter 2025 MD&A	PU
13/11	HLS Therapeutics Announces Q3 2025 Financial Results	AQ
30/10/25	HLS Therapeutics to Host Q3 2025 Financial Results Conference Call	AQ
14/10/25	HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress	AQ
20/08/25	HLS Therapeutics Announces New Credit Agreement	AQ
14/08/25	HLS Therapeutics : Q2 2025 Conference Call Presentation	PU
31/07/25	HLS Therapeutics to Host Q2 2025 Financial Results Conference Call	AQ
02/07/25	HLS Therapeutics Announces Reimbursement for Vascepa® under Nova Scotia's Provincial Drug Plan	AQ
20/06/25	HLS Therapeutics Reports Annual Meeting Results	AQ
28/04/25	HLS Therapeutics to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference	AQ
24/04/25	HLS Therapeutics to Host Q1 2025 Financial Results Conference Call	AQ
13/03/25	HLS Therapeutics : Q4 2024 Conference Call Presentation	PU